Delivery Order SPE2DB20D3303-SPE2DB24FZ8D8

Award Date 5/23/24
Potential Completion Date 5/24/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of 4,564,234,109 units of Zolmitriptan 5 mg nasal spray. The contract, valued at $25,260.90, is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical. It does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00, which serves as the...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Zolmitriptan 5 mg nasal spray. The contract has a ceiling value of $5,884.97 and a completion date of July 24, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,490,124 units of Zolmitriptan 5 mg nasal spray. The $5,064.97 contract has a completion date of January 31, 2024 and does not use any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of...
This federal contract award is for the delivery of Zolmitriptan 5 mg Nasal Spray in quantities of 6 per package to the Defense Logistics Agency (DLA). The contract, valued at $6,486.22, was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price, and the ultimate completion date is June 5, 2024. This contract award is not associated with a set-aside designation....
This federal contract award is for the delivery of Zolmitriptan 5 mg nasal spray to the Defense Logistics Agency (DLA), a defense agency. The $2,042.23 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,586.72 Firm Fixed Price Delivery Order covers the supply of Zolmitriptan 5 mg Nasal Spray. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $5,009.93 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of Zolmitriptan 5 mg nasal spray, with a performance period through March 28, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,741,631 units of Zolmitriptan 5 mg nasal spray, with a ceiling value of $4,918.74. The contract is a firm fixed-price delivery order, with a period of performance through May 30, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This federal contract award is for the delivery of Zolmitriptan 5 mg nasal spray to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $13,760.98 and an ultimate completion date of December 26, 2023. The contract was awarded on December 22, 2023 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,231,221 units of the drug Zolmitriptan 5 mg Nasal Spray, with a ceiling value of $5,312.95. The contract has an ultimate completion date of July 24, 2024 and is a firm fixed-price delivery order. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FZ8D8
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,698,068 units of Zolmitriptan 5 mg nasal spray, with a ceiling value of $1,024.85. The contract is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 24, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current award is not designated as a set-aside contract.

Generated 8/22/24, 3:25 PM